{"id":67771,"date":"2026-06-09T22:00:31","date_gmt":"2026-06-09T14:00:31","guid":{"rendered":"https:\/\/flcube.com\/?p=67771"},"modified":"2026-06-09T22:00:33","modified_gmt":"2026-06-09T14:00:33","slug":"boji-medical-raises-66-million-through-private-placement-to-expand-integrated-cro-and-tcm-innovation-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67771","title":{"rendered":"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Boji Medical Technology Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/300404:SHE\">SHE: 300404<\/a>), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to <strong>30% of its total share capital<\/strong>, raising <strong>RMB 447.73 million<\/strong> (approximately <strong>USD 66 million<\/strong>) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.<\/p>\n\n\n\n<h2 id=\"h-capital-raise-details\" class=\"wp-block-heading\">Capital Raise Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Boji Medical Technology Co., Ltd. (SHE: 300404)<\/td><\/tr><tr><td><strong>Transaction Type<\/strong><\/td><td>Private placement<\/td><\/tr><tr><td><strong>Equity Issued<\/strong><\/td><td>Up to 30% of total share capital<\/td><\/tr><tr><td><strong>Proceeds<\/strong><\/td><td>RMB 447.73 million (USD 66 million)<\/td><\/tr><tr><td><strong>Primary Use<\/strong><\/td><td>Strategic infrastructure and capability expansion<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-strategic-investment-allocation\" class=\"wp-block-heading\">Strategic Investment Allocation<\/h2>\n\n\n\n<h3 id=\"h-drug-evaluation-center-expansion-amp-upgrade\" class=\"wp-block-heading\">Drug Evaluation Center Expansion &amp; Upgrade<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Enhanced Capabilities<\/strong>: Strengthened pharmacology, toxicology, and safety evaluation services<\/li>\n\n\n\n<li><strong>Strategic Integration<\/strong>: Completes integrated layout spanning innovative drug R&amp;D, drug evaluation, clinical research, regulatory filing, and CDMO services<\/li>\n\n\n\n<li><strong>Capacity Increase<\/strong>: Expanded throughput for preclinical and non-clinical studies<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-innovative-traditional-chinese-medicine-tcm-r-amp-d\" class=\"wp-block-heading\">Innovative Traditional Chinese Medicine (TCM) R&amp;D<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pipeline Acceleration<\/strong>: Expedited development of proprietary TCM innovative drug candidates<\/li>\n\n\n\n<li><strong>Capability Enhancement<\/strong>: Elevated TCM-specific drug discovery and development expertise<\/li>\n\n\n\n<li><strong>Differentiation Strategy<\/strong>: Leverages China&#8217;s unique TCM heritage in modern drug development framework<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-intelligent-integrated-big-data-platform\" class=\"wp-block-heading\">Intelligent Integrated Big Data Platform<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Digital Transformation<\/strong>: Significant improvement in pharmaceutical R&amp;D digital capabilities<\/li>\n\n\n\n<li><strong>Data Integration<\/strong>: Unified platform connecting preclinical, clinical, and regulatory data streams<\/li>\n\n\n\n<li><strong>Operational Efficiency<\/strong>: Enhanced analytics and decision-making across the drug development lifecycle<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-smo-center-construction\" class=\"wp-block-heading\">SMO Center Construction<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Service Scale<\/strong>: Comprehensive enhancement of Site Management Organization (SMO) service capacity<\/li>\n\n\n\n<li><strong>Execution Efficiency<\/strong>: Improved clinical trial site management and patient recruitment capabilities<\/li>\n\n\n\n<li><strong>One-Stop Solution<\/strong>: Strengthened end-to-end CRO service offering from discovery through commercialization<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-context\" class=\"wp-block-heading\">Market Context<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>China CRO Market<\/strong>: Valued at USD 12.8 billion in 2025 with projected CAGR of 18.5% through 2030<\/li>\n\n\n\n<li><strong>Integrated Services Trend<\/strong>: Increasing demand for comprehensive CRO solutions covering the entire drug development continuum<\/li>\n\n\n\n<li><strong>TCM Innovation<\/strong>: Growing government support for modernizing traditional Chinese medicine through scientific validation<\/li>\n\n\n\n<li><strong>Digital Transformation<\/strong>: Accelerating adoption of big data and AI technologies across Chinese pharmaceutical R&amp;D landscape<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-forward-looking-statements\" class=\"wp-block-heading\">Forward-Looking Statements<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">This brief contains forward-looking statements regarding capital allocation, strategic initiatives, market opportunities, and business expansion plans. Actual results may differ due to risks including regulatory changes, competitive dynamics, execution challenges, and macroeconomic conditions affecting the Chinese biopharmaceutical sector.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/\u535a\u6d4e\u533b\u836f\uff1a2026\u5e74\u5ea6\u5411\u7279\u5b9a\u5bf9\u8c61\u53d1\u884c\u80a1\u7968\u9884\u6848.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u535a\u6d4e\u533b\u836f\uff1a2026\u5e74\u5ea6\u5411\u7279\u5b9a\u5bf9\u8c61\u53d1\u884c\u80a1\u7968\u9884\u6848.\"><\/object><a id=\"wp-block-file--media-460cbab0-29e5-47c1-ba6e-f0c24934b058\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/\u535a\u6d4e\u533b\u836f\uff1a2026\u5e74\u5ea6\u5411\u7279\u5b9a\u5bf9\u8c61\u53d1\u884c\u80a1\u7968\u9884\u6848.pdf\">\u535a\u6d4e\u533b\u836f\uff1a2026\u5e74\u5ea6\u5411\u7279\u5b9a\u5bf9\u8c61\u53d1\u884c\u80a1\u7968\u9884\u6848<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/\u535a\u6d4e\u533b\u836f\uff1a2026\u5e74\u5ea6\u5411\u7279\u5b9a\u5bf9\u8c61\u53d1\u884c\u80a1\u7968\u9884\u6848.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-460cbab0-29e5-47c1-ba6e-f0c24934b058\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[2956,1170],"class_list":["post-67771","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-boji-medical-technology","tag-she-300404"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to 30% of its total share capital, raising RMB 447.73 million (approximately USD 66 million) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67771\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform\" \/>\n<meta property=\"og:description\" content=\"Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to 30% of its total share capital, raising RMB 447.73 million (approximately USD 66 million) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67771\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-09T14:00:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T14:00:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67771#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67771\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform\",\"datePublished\":\"2026-06-09T14:00:31+00:00\",\"dateModified\":\"2026-06-09T14:00:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67771\"},\"wordCount\":360,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Boji Medical Technology\",\"SHE: 300404\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67771#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67771\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67771\",\"name\":\"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-09T14:00:31+00:00\",\"dateModified\":\"2026-06-09T14:00:33+00:00\",\"description\":\"Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to 30% of its total share capital, raising RMB 447.73 million (approximately USD 66 million) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67771#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67771\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67771#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to 30% of its total share capital, raising RMB 447.73 million (approximately USD 66 million) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67771","og_locale":"en_US","og_type":"article","og_title":"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform","og_description":"Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to 30% of its total share capital, raising RMB 447.73 million (approximately USD 66 million) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.","og_url":"https:\/\/flcube.com\/?p=67771","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-09T14:00:31+00:00","article_modified_time":"2026-06-09T14:00:33+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67771#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67771"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform","datePublished":"2026-06-09T14:00:31+00:00","dateModified":"2026-06-09T14:00:33+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67771"},"wordCount":360,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Boji Medical Technology","SHE: 300404"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67771#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67771","url":"https:\/\/flcube.com\/?p=67771","name":"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-09T14:00:31+00:00","dateModified":"2026-06-09T14:00:33+00:00","description":"Boji Medical Technology Co., Ltd. (SHE: 300404), a leading China-based Clinical Research Organization (CRO), announced today a private placement of up to 30% of its total share capital, raising RMB 447.73 million (approximately USD 66 million) to fund strategic expansion initiatives across its integrated pharmaceutical services platform.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67771#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67771"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67771#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Boji Medical Raises $66 Million Through Private Placement to Expand Integrated CRO and TCM Innovation Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67771"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67771\/revisions"}],"predecessor-version":[{"id":67774,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67771\/revisions\/67774"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}